Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 21,000 shares at $35.99 ($756K) on 2019-03-25, disclosed to the SEC on 2019-03-27.
Open-market sale of $756k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.99 | 19,700 | $709K | 93.8% |
| 2 | $36.00 | 1,000 | $36K | 4.8% |
| 3 | $36.64 | 300 | $11K | 1.5% |
| Total | $36.00 avg | 21,000 | $756K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |